Evidence map›Paper›PMID 30862327›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2019

Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain.

Ana Belen Pérez, Bram Vrancken, Natalia Chueca, Antonio Aguilera, Gabriel Reina, Miguel García-Del Toro, Francisco Vera, Miguel Angel Von Wichman, Juan Ignacio Arenas, Francisco Téllez and 10 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dynamics and Dispersal of Local Human Immunodeficiency Virus Epidemics Within San Diego and Across the San Diego-Tijuana Border.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ana Belen PérezDepartment of Microbiology, Institute of Bio Sanitary Research (IBIS), AIDS Research Network, University Hospital of Granada, Granada, Spain.
Bram VranckenThese authors contributed equally to the article.
Natalia ChuecaDepartment of Microbiology, Institute of Bio Sanitary Research (IBIS), AIDS Research Network, University Hospital of Granada, Granada, Spain.
Antonio AguileraDepartment of Microbiology, University Hospital of Santiago, Santiago de Compostela, Spain.
Gabriel ReinaDepartment of Microbiology, University Hospital of Navarra, Institute for Health Research (IdisNA), Pamplona, Spain.
Miguel García-Del ToroUnit of Infectious Diseases, General Hospital of Valencia, Valencia.
Francisco VeraUnit of Infectious Diseases, Internal Medicine, General Hospital of Rosell, Cartagena, Murcia, Spain.
Miguel Angel Von WichmanUnit of Infectious Diseases, Hospital Universitario de San Sebastian, San Sebastian, Spain.
Juan Ignacio ArenasUnit of Infectious Diseases, Hospital Universitario de San Sebastian, San Sebastian, Spain.
Francisco TéllezUnit of Infectious Diseases and Microbiology, University Hospital of Puerto Real, Cádiz, Spain.
Juan A PinedaUnit of Infectious Diseases, University Hospital of Valme, Sevilla, Spain (J.A. Pineda).
Mohamed OmarUniversity Hospital of Jaen, Jaen, Spain.
Enrique BernalUnit of Infectious Diseases, General University Hospital, Murcia, Spain.
Antonio Rivero-JuárezUnit of Infectious Diseases, University Hospital Reina Sofía of Córdoba, Maimonides Institute of Biomedical Research of Córdoba, University of Córdoba, Córdoba, Spain.
Elisa Fernández-FuertesUnit of Tropical Medicine, Hospital of Poniente, El Ejido, Almería, Spain.
Alberto de la IglesiaDepartment of Microbiology, Hospital Infanta Elena of Huelva, Huelva, Spain.
Juan Manuel PascasioClinical Management Unit of Digestive Diseases, University Hospital of Virgen del Rocío, Sevilla, Spain.
Philippe LemeyKU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Evolutionary and Computational Virology, Leuven, Belgium.
Féderico GarciaDepartment of Microbiology, Institute of Bio Sanitary Research (IBIS), AIDS Research Network, University Hospital of Granada, Granada, Spain.
Lize CuypersKU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundReducing the burden of the hepatitis C virus (HCV) requires large-scale deployment of intervention programmes, which can be informed by the dynamic pattern of HCV spread. In Spain, ongoing transmission of HCV is mostly fuelled by people who inject drugs (PWID) infected with subtype 1a (HCV1a).AimOur aim was to map how infections spread within and between populations, which could help formulate more effective intervention programmes to halt the HCV1a epidemic in Spain.MethodsEpidemiological links between HCV1a viruses from a convenience sample of 283 patients in Spain, mostly PWID, collected between 2014 and 2016, and 1,317, 1,291 and 1,009 samples collected abroad between 1989 and 2016 were reconstructed using sequences covering the NS3, NS5A and NS5B genes. To efficiently do so, fast maximum likelihood-based tree estimation was coupled to a flexible Bayesian discrete phylogeographic inference method.ResultsThe transmission network structure of the Spanish HCV1a epidemic was shaped by continuous seeding of HCV1a into Spain, almost exclusively from North America and European countries. The latter became increasingly relevant and have dominated in recent times. Export from Spain to other countries in Europe was also strongly supported, although Spain was a net sink for European HCV1a lineages. Spatial reconstructions showed that the epidemic in Spain is diffuse, without large, dominant within-country networks.ConclusionTo boost the effectiveness of local intervention efforts, concerted supra-national strategies to control HCV1a transmission are needed, with a strong focus on the most important drivers of ongoing transmission, i.e. PWID and other high-risk populations.

Indexed as

EpidemicsGenome, ViralGenotypeHepacivirusHepatitis CHumansPhylogenyPrevalenceRNA, ViralSequence Analysis, DNASequence Analysis, RNASpainRNA, ViralEuropeHCV1ahepatitis C virusNorth Americaphylogeographypublic healthpublic health policySpain

Identifiers

PMID30862327
PMCPMC6402173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.